Patients with heart failure have lower risk of death if seen by physician in first week after discharge from ED Certain oral tyrosine kinase inhibitors linked to artery dissections and aneurysmsAbnormal structural changes of the arterial wall have been reported with VEGFR TKI use in patients with or without hypertension Empagliflozin improves survival in type 2 diabetes patients with established cardiovascular disease Estimated to improve life expectancy by one to 4.5 years according to an analysis of data from a major trial Methotrexate underperforms as an alternative for lowering inflammation linked to cardiovascular events Study shows little heart help from Vitamin D, omega-3 Watch for lung cancer risk in patients taking ACE inhibitors Study questions clinical guidelines for antihypertensive treatment 5 tips for interpreting home blood pressure measurements Invokana now indicated to reduce the risk of major cardiovascular events Health Canada approves new tests for diagnosing heart attacks faster Two innovative assays that can shorten the time required to diagnose life-threatening heart attacks have been licensed for sale by Health Canada. First Previous 28 29 30 31 32 Next Last
